Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Brenneman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancers|November 13, 2021
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of ImmunotherapyRe-I Chin, Joshua P Schiff, Randall J Brenneman, et al.
Annals of Surgical Oncology|October 19, 2020
Reduced Wide Local Excision Margins are Associated with Increased Risk of Relapse and Death from Merkel Cell CarcinomaNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
Cureus|March 6, 2023
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation TherapyMichael R Waters, Neal Andruska, Benjamin W Fischer-Valuck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology|October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal SarcomaRandall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
Aptamer-mediated transcriptional gene silencing of <i>Fox</i> <i>p</i> <i>3</i> inhibits regulatory T cells and potentiates antitumor responseAndrea J Manrique-Rincón, Luciana P Ruas, Carolinne T Fogagnolo, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancers|November 13, 2021
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of ImmunotherapyRe-I Chin, Joshua P Schiff, Randall J Brenneman, et al.
Annals of Surgical Oncology|October 19, 2020
Reduced Wide Local Excision Margins are Associated with Increased Risk of Relapse and Death from Merkel Cell CarcinomaNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
Cureus|March 6, 2023
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation TherapyMichael R Waters, Neal Andruska, Benjamin W Fischer-Valuck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology|October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal SarcomaRandall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
Aptamer-mediated transcriptional gene silencing of <i>Fox</i> <i>p</i> <i>3</i> inhibits regulatory T cells and potentiates antitumor responseAndrea J Manrique-Rincón, Luciana P Ruas, Carolinne T Fogagnolo, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Pageof 2